EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer

Aynura Mammadova, Yuan Gu, Ling Ruan, Sunil S Badve iD, Yesim Gökmen-Polar iD

Biomolecules · 06.01.2026 · 16 (1) · 93

DOI: 10.3390/biom16010093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 06.01.2026. Verfasst von Aynura Mammadova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Breast Neoplasms, Protein Kinase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Susan G. Komen Breast Cancer Foundation, Winship Cancer Institute, Susan G. Komen for the Cure.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) have transformed the treatment landscape for estrogen receptor-positive (ER+) breast cancer, yet resistance remains a major clinical challenge. Although CDK4/6i induce G1 arrest and therapy-induced senescence (TIS), the exact nature of this senescent state and its contribution to resistance are not well understood. To explore this, we developed palbociclib- (2PR, 9PR, TPR) and abemaciclib- (2AR, 9AR, TAR) resistant ER+ breast cancer sublines through prolonged drug exposure over six months. Resistant cells demonstrated distinct phenotypic alterations, including cellular senescence, reduced mitochondrial membrane potential, and impaired glycolytic activity. Cytokine profiling and enzyme-linked immunosorbent assay (ELISA) validation revealed a non-canonical senescence-associated secretory phenotype (SASP) characterized by elevated growth/differentiation factor 15 (GDF-15) and serpin E1 (plasminogen activator inhibitor-1, PAI-1) and absence of classical pro-inflammatory interleukins, including IL-1α and IL-6. IL-8 levels were significantly elevated, but no association with epithelial–mesenchymal transition (EMT) was observed. Resistant cells preserved their epithelial morphology, showed no upregulation of EMT markers, and lacked aldehyde dehydrogenase 1-positive (ALDH1+) stem-like populations. Additionally, Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) was strongly upregulated in palbociclib-resistant cells. Together, these findings identify a distinct, non-canonical senescence phenotype associated with CDK4/6i resistance and may provide a foundation for identifying new vulnerabilities in resistant ER+ breast cancers through targeting SASP-related signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Breast NeoplasmsProtein Kinase InhibitorsDrug Resistance, NeoplasmCellular SenescenceReceptors, EstrogenHumansFemalePyridinesPiperazinesBenzimidazolesAminopyridinesCell Line, TumorSenescence-Associated Secretory Phenotype

Stichwörter der Autor:innen

CDK4/6 inhibitorsbreast cancerresistance to cancer therapiestherapy-induced senescence

Substanzen

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6palbociclibPyridinesProtein Kinase InhibitorsPiperazinesCDK6 protein, humanCDK4 protein, humanReceptors, Estrogenabemaciclib

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Sunil S Badve, Yesim Gökmen-Polar

Förderung

  • Susan G. Komen Breast Cancer Foundation
  • Winship Cancer Institute
  • Susan G. Komen for the Cure
  • Winship Invest$ Winter 2022 grant
  • Emory University

Zitieren

APA

Mammadova, A., Gu, Y., Ruan, L., Badve, S. S., & Gökmen-Polar, Y. (2026). Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer. Biomolecules, 16(1), 93. https://doi.org/10.3390/biom16010093

Vancouver

Mammadova A, Gu Y, Ruan L, Badve SS, Gökmen-Polar Y. Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer. Biomolecules. 2026;16(1):93. doi:10.3390/biom16010093

BibTeX
@article{Mammadova2026,
  author = {Mammadova, Aynura and Gu, Yuan and Ruan, Ling and Badve, Sunil S and Gökmen-Polar, Yesim},
  title = {Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {93},
  doi = {10.3390/biom16010093}
}
Kostenlos starten →